V. Sathiyanarayanan, P. Varun Prasath, P. Chandra Sekhar, K. Ravichandran, D. Easwaramoorthy, Faruq Mohammad, Hamad A. Al-Lohedan, Won Chun Oh and Suresh Sagadevan

RSC Adv., 2020, 10, 16457
DOI: 10.1039/D0RA01936D

Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation

Linlin Li, Wenqiang Cao, Wenjie Zheng, Cundong Fan and Tianfeng Chen

Dalton Trans., 2012, 41, 12766
DOI: 10.1039/c2dt30665d

Functionalized halloysite nanotube by chitosan grafting for drug delivery of curcumin to achieve enhanced anticancer efficacy

Mingxian Liu, Yanzhou Chang, Jing Yang, Yuanyuan You, Rui He, Tianfeng Chen and Changren Zhou

J. Mater. Chem. B, 2016, 4, 2253
DOI: 10.1039/C5TB02725J

Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy

Jinggong Liu, Haoqiang Lai, Zushuang Xiong, Bolai Chen and Tianfeng Chen

Chem. Commun., 2019, 55, 9904
DOI: 10.1039/C9CC04098F

Imidazole derivatives: A comprehensive survey of their recognition properties

Pedro Molina, Alberto Tárraga and Francisco Otón

Org. Biomol. Chem., 2012, 10, 1711
DOI: 10.1039/c2ob06808g

DNA-binding, molecular docking studies and biological activity studies of ruthenium(ii) polypyridyl complexes

Bing Tang, Fang Shen, Dan Wan, Bo-Hong Guo, Yang-Jie Wang, Qiao-Yan Yi and Yun-Jun Liu

RSC Adv., 2017, 7, 34945
DOI: 10.1039/C7RA05103D

Novel ruthenium(ii) polypyridyl complexes as G-quadruplex stabilisers and telomerase inhibitors

Guoliang Liao, Xiang Chen, Jingheng Wu, Chen Qian, Hanqiang Wang, Liangnian Ji and Hui Chao

Dalton Trans., 2014, 43, 7811
DOI: 10.1039/c3dt53547a

Synthesis, relaxivity, and in vitro fluorescence imaging studies of a novel d–f heterometallic trinuclear complex as a potential bimodal imaging probe for MRI and optical imaging

A. Nithyakumar and V. Alexander

Dalton Trans., 2015, 44, 17800
DOI: 10.1039/C5DT02123E

Synthesis and biological evaluation of heterocyclic hydrazone transition metal complexes as potential anticancer agents

Yunpeng Du, Wei Chen, Xiang Fu, Hang Deng and JunGang Deng

RSC Adv., 2016, 6, 109718
DOI: 10.1039/C6RA23477A

Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways

Haoqiang Lai, Zhennan Zhao, Linlin Li, Wenjie Zheng and Tianfeng Chen

Metallomics, 2015, 7, 439
DOI: 10.1039/C4MT00312H

Zinc(ii) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells

Shenggui Liu, Wenqiang Cao, Lianling Yu, Wenjie Zheng, Linlin Li, Cundong Fan and Tianfeng Chen

Dalton Trans., 2013, 42, 5932
DOI: 10.1039/c3dt33077j

Investigation of inducing apoptosis in human lung cancer A549 cells and related mechanism of a ruthenium(II) polypyridyl complex

Jin-can Chen, Guo-dong Li, Fa Peng, Xin-ming Jie, Guang-zhi Dongye, Yu Zhong, Rui-bing Feng, Bao-jun Li, Jiao-yue Qu, Yan Ding and Lan-mei Chen

Inorganic Chemistry Communications, 2016, 69, 35
DOI: 10.1016/j.inoche.2016.04.025

Syntheses, spectra, photoinduced nitric oxide release and interactions with biomacromolecules of three nitrosylruthenium complexes

Luna Song, Leilei Xie, Liqun Xu, Qi Jing, Chenyang Liu, Xiaoli Xi, Wenming Wang, Yi Zhao, Xuan Zhao and Hongfei Wang

Polyhedron, 2020, 185, 114596
DOI: 10.1016/j.poly.2020.114596

Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii

Afonso P. Basto, Joachim Müller, Riccardo Rubbiani, David Stibal, Federico Giannini, Georg Süss-Fink, Vreni Balmer, Andrew Hemphill, Gilles Gasser and Julien Furrer

Antimicrob Agents Chemother, 2017, 61
DOI: 10.1128/AAC.01031-17

Luminescence properties and DFT calculations of lanthanide(III) complexes (Ln = La, Nd, Sm, Eu, Gd, Tb, Dy) with 2,6-bis(5-methyl-benzimidazol-2-yl)pyridine

Antonio Cruz-Navarro, José María Rivera, Jesús Durán-Hernández, Silvia Castillo-Blum, Angelina Flores-Parra, Mario Sánchez, Irán Hernández-Ahuactzi and Raúl Colorado-Peralta

Journal of Molecular Structure, 2018, 1164, 209
DOI: 10.1016/j.molstruc.2018.03.065

An overview of advancement of organoruthenium(II) complexes as prospective anticancer agents

Masrat Bashir, Imtiyaz Ahmad Mantoo, Farukh Arjmand, Sartaj Tabassum and Imtiyaz Yousuf

Coordination Chemistry Reviews, 2023, 487, 215169
DOI: 10.1016/j.ccr.2023.215169

Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells

Jin-Quan Wang, Ping-Yu Zhang, Chen Qian, Xiao-Juan Hou, Liang-Nian Ji and Hui Chao

J Biol Inorg Chem, 2014, 19, 335
DOI: 10.1007/s00775-013-1069-2

Review of synthesis process of benzimidazole-heterocycle hybrid compounds

Abouelhaoul El Alami, Hamid Sdassi and Said Bouzikri

Synthetic Communications, 2024, 54, 613
DOI: 10.1080/00397911.2024.2316718

Cancer‐Targeted Monodisperse Mesoporous Silica Nanoparticles as Carrier of Ruthenium Polypyridyl Complexes to Enhance Theranostic Effects

Lizhen He, Yanyu Huang, Huili Zhu, Guanhua Pang, Wenjie Zheng, Yum‐Shing Wong and Tianfeng Chen

Adv Funct Materials, 2014, 24, 2754
DOI: 10.1002/adfm.201303533

A multifunctional DNA origami as carrier of metal complexes to achieve enhanced tumoral delivery and nullified systemic toxicity

Yanyu Huang, Wei Huang, Leung Chan, Binwei Zhou and Tianfeng Chen

Biomaterials, 2016, 103, 183
DOI: 10.1016/j.biomaterials.2016.06.053

Cytoxicity and Apoptotic Mechanism of Ruthenium(II) Amino Acid Complexes in Sarcoma-180 Tumor Cells

Aliny Pereira Lima, Flávia Castro Pereira, Marcio Aurelio Pinheiro Almeida, Francyelli Mariana Santos Mello, Wanessa Carvalho Pires, Thallita Monteiro Pinto, Flávia Karina Delella, Sérgio Luis Felisbino, Virtudes Moreno, Alzir Azevedo Batista, Elisângela de Paula Silveira-Lacerda and Arun Rishi

PLoS ONE, 2014, 9, e105865
DOI: 10.1371/journal.pone.0105865

Cell cycle, apoptosis, cellular uptake and whole-transcriptome microarray gene expression analysis of HeLa cells treated with a ruthenium(II)-arene complex with an isoquinoline-3-carboxylic acid ligand

Katarina K. Jovanović, Miljana Tanić, Ivanka Ivanović, Nevenka Gligorijević, Biljana P. Dojčinović and Siniša Radulović

Journal of Inorganic Biochemistry, 2016, 163, 362
DOI: 10.1016/j.jinorgbio.2016.04.011

Novel hybrid materials based on heteroleptic Ru(III) complexes immobilized on SBA-15 mesoporous silica as highly potent antimicrobial and cytotoxic agents

Gabriela Marinescu, Daniela C. Culita, Cosmin Romanitan, Simona Somacescu, Cristian D. Ene, Virgil Marinescu, Dragos G. Negreanu, Catalin Maxim, Marcela Popa, Luminita Marutescu, Miruna Stan and Carmen Chifiriuc

Applied Surface Science, 2020, 520, 146379
DOI: 10.1016/j.apsusc.2020.146379

Organometallic ruthenium and iridium phosphorus complexes: Synthesis, cellular imaging, organelle targeting and anticancer applications

JuanJuan Li, Zhenzhen Tian, Shumiao Zhang, Zhishan Xu, Xudong Mao, Yumin Zhou and Zhe Liu

Applied Organom Chemis, 2019, 33
DOI: 10.1002/aoc.4685

Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-pyrimidine-4-carboxylic Acid

Vanessa Pierroz, Tanmaya Joshi, Anna Leonidova, Cristina Mari, Julia Schur, Ingo Ott, Leone Spiccia, Stefano Ferrari and Gilles Gasser

J. Am. Chem. Soc., 2012, 134, 20376
DOI: 10.1021/ja307288s

Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent Advances

Mohamed A. S. Badawy, Stefan Bräse, Taha F. S. Ali, Mohamed Abdel-Aziz and Hamdy M. Abdel-Rahman

Pharmaceuticals, 2025, 18, 1454
DOI: 10.3390/ph18101454

Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway

Guang-Bin Jiang, Xiang Zheng, Jun-Hua Yao, Bing-Jie Han, Wei Li, Ji Wang, Hong-Liang Huang and Yun-Jun Liu

Journal of Inorganic Biochemistry, 2014, 141, 170
DOI: 10.1016/j.jinorgbio.2014.09.001

Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism

Zhenlei Zhang, Yi Gou, Jun Wang, Kun Yang, Jinxu Qi, Zuping Zhou, Shichu Liang, Hong Liang and Feng Yang

European Journal of Medicinal Chemistry, 2016, 121, 399
DOI: 10.1016/j.ejmech.2016.05.021

A bis-indazolic ruthenium(II) complex: Reactivity and biological studies on cancer cells

Danilo K.S. Sales, Lílian M.T. Simplício, Carlos D.S. da Silva, Carolina M.B. Enju, Vanessa B. Silva, Tércio de F. Paulo, Ivanilson P. Santos, Helenita C. Quadros, Cássio S. Meira, Milena B.P. Soares, Luiz G. de F. Lopes, Eduardo H.S. de Sousa and Denise S. de Sá

Inorganica Chimica Acta, 2021, 516, 120125
DOI: 10.1016/j.ica.2020.120125

Photocontrolled nitric oxide release from two nitrosylruthenium isomer complexes and their potential biomedical applications

Jiao Liu, Qingqing Duan, Jianru Wang, Zhen Song, Xiaoyan Qiao and Hongfei Wang

J. Biomed. Opt, 2015, 20, 015004
DOI: 10.1117/1.JBO.20.1.015004

Study of the cytotoxic and genotoxic potential of the carbonyl ruthenium(II) compound, ct‐[RuCl(CO)(dppb)(bipy)]PF6 [dppb = 1,4‐bis(diphenylphosphino)butane and bipy = 2,2′‐bipyridine], by in vitro and in vivo assays

Andréa P. Carnizello, Jacqueline M. Alves, Daiane E. Pereira, Jacqueline C. L. Campos, Marília I. F. Barbosa, Alzir A. Batista and Denise C. Tavares

J of Applied Toxicology, 2019, 39, 630
DOI: 10.1002/jat.3753

A comparison of in vitro studies between cobalt(III) and copper(II) complexes with thiosemicarbazone ligands to treat triple negative breast cancer

Duaa R. Alajroush, Chloe B. Smith, Brittney F. Anderson, Ifeoluwa T. Oyeyemi, Stephen J. Beebe and Alvin A. Holder

Inorganica Chimica Acta, 2024, 562, 121898
DOI: 10.1016/j.ica.2023.121898

Bioreducible and traceable Ru(III) prodrug-loaded mesoporous silica nanoparticles for sequentially targeted nonsmall cell lung cancer chemotherapy

Fangman Chen, Fan Zhang, Dan Shao, Weibin Zhang, Liqin Zheng, Wei Wang, Wendi Yang, Zheng Wang, Jianxin Chen, Wen-fei Dong, Fangnan Xiao and Yunkun Wu

Applied Materials Today, 2020, 19, 100558
DOI: 10.1016/j.apmt.2020.100558

Copper(II), cobalt(II) and zinc(II) complexes based on a tridentate bis(benzimidazole)pyridine ligand: synthesis, crystal structures, electrochemical properties and antitumour activities

Rong-Kai Pan, Jiang-Li Song, Guo-Bi Li, San-Qing Lin, Sheng-Gui Liu and Gui-Zhen Yang

Transit Met Chem, 2017, 42, 253
DOI: 10.1007/s11243-017-0129-9

Novel synthetic bisbenzimidazole that targets angiogenesis in Ehrlich ascites carcinoma bearing mice

Rangaswamy Roopashree, Chakrabhavi Dhananjaya Mohan, Toreshettahally Ramesh Swaroop, Swamy Jagadish, Byregowda Raghava, Kyathegowdanadoddi Srinivas Balaji, Shankar Jayarama, Basappa and Kanchugarakoppal Subbegowda Rangappa

Bioorganic & Medicinal Chemistry Letters, 2015, 25, 2589
DOI: 10.1016/j.bmcl.2015.04.010

Comparative studies on DNA-binding and in vitro antitumor activity of enantiomeric ruthenium(II) complexes

Wen-Xu Hong, Fengwen Huang, Tianwen Huan, Xu Xu, Qingguo Han, Gaofeng Wang, Hong Xu, Shan Duan, Yongheng Duan, Xun Long, Ying Liu and Zhangli Hu

Journal of Inorganic Biochemistry, 2018, 180, 54
DOI: 10.1016/j.jinorgbio.2017.11.024

An Overview of the Potential Medicinal and Pharmaceutical Properties of Ru(II)/(III) Complexes

Anna Skoczynska, Andrzej Lewinski, Mateusz Pokora, Piotr Paneth and Elzbieta Budzisz

IJMS, 2023, 24, 9512
DOI: 10.3390/ijms24119512

3-(1H-benzoimidazol-2-yl)-chromen-2-ylideneamine platinum(II) and ruthenium(II) complexes exert their high in vitro antitumor activity by inducing S-phase arrest and disrupting mitochondrial functions in SK-OV-3/DDP tumor cells

Qi-Pin Qin, Shu-Long Wang, Ming-Xiong Tan, Dong-Mei Luo, Zhen-Feng Wang, Qing-Min Wei, Xue-Yu Wu, Bi-Qun Zou and Yan-Cheng Liu

Polyhedron, 2019, 157, 219
DOI: 10.1016/j.poly.2018.10.012

Synthesis, characterization and theoretical studies of the heteroleptic Ruthenium(II) complexes of 2,6-bis(benzimidazolyl)pyridine

Sumita Naskar, Bholanath Pakhira, Dipankar Mishra, Partha Mitra, Shyamal Kumar Chattopadhyay and Subhendu Naskar

Polyhedron, 2015, 100, 170
DOI: 10.1016/j.poly.2015.07.058

Photo-induced cytotoxicity, photo-controlled nitric oxide release and DNA/human serum albumin binding of three water-soluble nitrosylruthenium complexes

Liqun Xu, Zhiou Ma, Wenming Wang, Leilei Xie, Lifang Liu, Jiao Liu, Xuan Zhao and Hongfei Wang

Polyhedron, 2017, 137, 157
DOI: 10.1016/j.poly.2017.08.036

Ruthenium(II)/Benzonitrile Complex Induces Cytotoxic Effect in Sarcoma-180 Cells by Caspase-Mediated and Tp53/p21-Mediated Apoptosis, with Moderate Brine Shrimp Toxicity

Raquel Santos Faria, Hugo Delleon Silva, Francyelli Mello-Andrade, Wanessa Carvalho Pires, Flávia de Castro Pereira, Aliny Pereira de Lima, Sônia de Fátima Oliveira Santos, Thallita Monteiro Teixeira, Paula Francinete Faustino da Silva, Plínio Lázaro Faleiro Naves, Alzir Azevedo Batista, Renato José da Silva Oliveira, Rui Manuel Reis and Elisângela de Paula Silveira-Lacerda

Biol Trace Elem Res, 2020, 198, 669
DOI: 10.1007/s12011-020-02098-8

Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase

Jin-can Chen, Yao Zhang, Xin-ming Jie, Ji She, Guang-zhi Dongye, Yu Zhong, Yuan-yuan Deng, Jie Wang, Bo-yang Guo and Lan-mei Chen

Journal of Inorganic Biochemistry, 2019, 193, 112
DOI: 10.1016/j.jinorgbio.2019.01.011

The Novel 5-Fluorouracil Loaded Ruthenium-based Nanocarriers Enhanced Anticancer and Apoptotic Efficiency while Reducing Multidrug Resistance in Colorectal Cancer Cells

Ferdane Danişman-Kalindemirtaş, Dilşad Özerkan, İshak Afşin Kariper and Huri Bulut

J Fluoresc, 2023, 33, 1227
DOI: 10.1007/s10895-023-03180-9

[Ru(pipe)(dppb)(bipy)]PF6: A novel ruthenium complex that effectively inhibits ERK activation and cyclin D1 expression in A549 cells

Guilherme A. Ferreira-Silva, Marina M. Ortega, Marco A. Banionis, Graciana Y. Garavelli, Felipe T. Martins, Julia S.M. Dias, Cláudio Viegas Jr, Jaqueline C. de Oliveira, Fabio B. do Nascimento, Antonio C. Doriguetto, Marilia I.F. Barbosa and Marisa Ionta

Toxicology in Vitro, 2017, 44, 382
DOI: 10.1016/j.tiv.2017.07.019

Antiproliferative activity of ruthenium complex II against human cancer cell in vitro

Mohamed Saadh

PHAR, 2023, 70, 797
DOI: 10.3897/pharmacia.70.e111410

New Nanostructured Materials Based on Mesoporous Silica Loaded with Ru(II)/Ru(III) Complexes with Anticancer and Antimicrobial Properties

Gabriela Marinescu, Daniela C. Culita, Teodora Mocanu, Raul-Augustin Mitran, Simona Petrescu, Miruna S. Stan, Mariana C. Chifiriuc and Marcela Popa

Pharmaceutics, 2023, 15, 1458
DOI: 10.3390/pharmaceutics15051458

Recent Advances in Mitochondria‐Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer Agents

Sushree Aradhana Patra, Gurunath Sahu, Sanchita Das and Rupam Dinda

ChemMedChem, 2023, 18
DOI: 10.1002/cmdc.202300397

Applications of Ruthenium Complex in Tumor Diagnosis and Therapy

Ke Lin, Zi-Zhuo Zhao, Hua-Ben Bo, Xiao-Juan Hao and Jin-Quan Wang

Front. Pharmacol., 2018, 9
DOI: 10.3389/fphar.2018.01323

In vitro and in vivo anti-proliferative evaluation of bis(4′-(4-tolyl)-2,2′:6′,2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors

Dharmasivam Mahendiran, Raju Senthil Kumar, Vijayan Viswanathan, Devadasan Velmurugan and Aziz Kalilur Rahiman

J Biol Inorg Chem, 2017, 22, 1109
DOI: 10.1007/s00775-017-1488-6

Monitoring Cellular Uptake and Cytotoxicity of Copper(II) Complex Using a Fluorescent Anthracene Thiosemicarbazone Ligand

Anup N. Kate, Anupa A. Kumbhar, Ayesha A. Khan, Pranaya V. Joshi and Vedavati G. Puranik

Bioconjugate Chem., 2014, 25, 102
DOI: 10.1021/bc400385d

Synthesis and Antiproliferative Activity of New Ruthenium Complexes with Ethacrynic-Acid-Modified Pyridine and Triphenylphosphine Ligands

Gabriele Agonigi, Tina Riedel, Stefano Zacchini, Emilia Păunescu, Guido Pampaloni, Niccolò Bartalucci, Paul J. Dyson and Fabio Marchetti

Inorg. Chem., 2015, 54, 6504
DOI: 10.1021/acs.inorgchem.5b00802

Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation

Wanessa Carvalho Pires, Benedicto Augusto Vieira Lima, Flávia de Castro Pereira, Aliny Pereira Lima, Francyelli Mello-Andrade, Hugo Delleon Silva, Monize Martins da Silva, Legna Colina-Vegas, Javier Ellena, Alzir A. Batista and Elisângela de Paul Silveira-Lacerda

Mol Cell Biochem, 2018, 438, 199
DOI: 10.1007/s11010-017-3129-3

Transition metal complexes as photosensitizers for integrated cancer theranostic applications

Juanjuan Li and Tianfeng Chen

Coordination Chemistry Reviews, 2020, 418, 213355
DOI: 10.1016/j.ccr.2020.213355

Study on new series of bis-benzimidazole derivatives synthesis, characterization, single crystal XRD, biological activity and molecular docking

Karthik Rajagopal, Saravanan Dhandayutham, Manivannan Nandhagopal and Mathivanan Narayanasamy

Journal of Molecular Structure, 2023, 1283, 135253
DOI: 10.1016/j.molstruc.2023.135253

Cobalt (III) complex exerts anti-cancer effects on T cell lymphoma through induction of cell cycle arrest and promotion of apoptosis

Praveen Kumar Verma, Rishi Kant Singh, Sandeep Kumar, Alok Shukla, Sanjay Kumar, Mannu Kumar Gond, Manoj Kumar Bharty and Arbind Acharya

DARU J Pharm Sci, 2022, 30, 127
DOI: 10.1007/s40199-022-00439-7

Syntheses, characterizations, and antimicrobial activities of binuclear ruthenium(III) complexes containing 2-substituted benzimidazole derivatives

B. Roopashree, V. Gayathri, A. Gopi and K.S. Devaraju

Journal of Coordination Chemistry, 2012, 65, 4023
DOI: 10.1080/00958972.2012.731050

Two wheel-shaped Pr(III) and Er(III) complexes with long flexible ligand: Crystal structure, fluorescence and anticancer studies

Mingchang Zhu, Xiaopeng Zhu, Shuangyan Wu, Ying Zhang, Xiaoxi Ji, Qing Chen and Enjun Gao

Inorganic Chemistry Communications, 2020, 122, 108270
DOI: 10.1016/j.inoche.2020.108270

Brush-shaped RAFT polymer micelles as nanocarriers for a ruthenium (II) complex photodynamic anticancer drug

Dan Wang, Jinquan Wang, Haien Huang, Zizhuo Zhao, Pathiraja A. Gunatillake and Xiaojuan Hao

European Polymer Journal, 2019, 113, 267
DOI: 10.1016/j.eurpolymj.2019.01.074

The studies on the cytotoxicity in vitro, cellular uptake, cell cycle arrest and apoptosis-inducing properties of ruthenium methylimidazole complex [Ru(MeIm)4(p-cpip)]2+

Lan-mei Chen, Fa Peng, Guo-dong Li, Xin-ming Jie, Kang-rong Cai, Chun Cai, Yu Zhong, Hua Zeng, Wu Li, Zhen Zhang and Jin-can Chen

Journal of Inorganic Biochemistry, 2016, 156, 64
DOI: 10.1016/j.jinorgbio.2015.12.016

Second and third-row transition metal compounds containing benzimidazole ligands: An overview of their anticancer and antitumour activity

Galdina V. Suárez-Moreno, Delia Hernández-Romero, Óscar García-Barradas, Óscar Vázquez-Vera, Sharon Rosete-Luna, Carlos A. Cruz-Cruz, Aracely López-Monteon, Jesús Carrillo-Ahumada, David Morales-Morales and Raúl Colorado-Peralta

Coordination Chemistry Reviews, 2022, 472, 214790
DOI: 10.1016/j.ccr.2022.214790

Insights into the in vitro Anticancer Effects of Diruthenium‐1

Aneta Koceva‐Chyła, Karolina Matczak, Msc. Paweł Hikisz, Msc. Kamil Durka, Msc. Krzysztof Kochel, Georg Süss‐Fink, Julien Furrer and Konrad Kowalski

ChemMedChem, 2016, 11, 2171
DOI: 10.1002/cmdc.201600315

New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential

Ana Rita Brás, Pedro Fernandes, Tiago Moreira, Julia Morales-Sanfrutos, Eduard Sabidó, Alexandra M. M. Antunes, Andreia Valente and Ana Preto

Pharmaceutics, 2023, 15, 1731
DOI: 10.3390/pharmaceutics15061731

Synthesis and structural characterization of C,N-benzimidazole based ruthenium(II) complex with in vitro anticancer activity

Keerthika Kumarasamy, Tamiloli Devendhiran, Shibu Marthandam Asokan, Ramasamy Mahendran, Mei-Ching Lin, Wei-Jyun Chien, Selva Kumar Ramasamy and Chih-Yang Huang

Inorganic Chemistry Communications, 2023, 152, 110662
DOI: 10.1016/j.inoche.2023.110662

Enhancement of Antiangiogenic Efficacy of Iron(II) Complex by Selenium Substitution

Haoqiang Lai, Xiang Zhang, Pengju Feng, Lina Xie, Jinjin Chen and Tianfeng Chen

Chemistry An Asian Journal, 2017, 12, 982
DOI: 10.1002/asia.201700272

Mitochondria-Targeting Anticancer Metal Complexes

Andrea Erxleben

CMC, 2019, 26, 694
DOI: 10.2174/0929867325666180307112029

Bis(thiosemicarbazone)copper(I) Complexes as Prospective Therapeutic Agents: Interaction with DNA/BSA Molecules, and In Vitro and In Vivo Anti‐Proliferative Activities

Dharmasivam Mahendiran, Narayanaperumal Pravin, Nattamai S. P. Bhuvanesh, Raju Senthil Kumar, Vijayan Viswanathan, Devadasan Velmurugan and Aziz Kalilur Rahiman

ChemistrySelect, 2018, 3, 7100
DOI: 10.1002/slct.201800934

Revolutionizing anticancer treatment: Ruthenium-based nanoplatforms pave new paths

Dipanjan Karati, Shreyasi Meur, Swarupananda Mukherjee and Souvik Roy

Coordination Chemistry Reviews, 2024, 519, 216118
DOI: 10.1016/j.ccr.2024.216118

Aquation Is a Crucial Activation Step for Anticancer Action of Ruthenium(II) Polypyridyl Complexes to Trigger Cancer Cell Apoptosis

Meng Li, Lanhai Lai, Zhennan Zhao and Tianfeng Chen

Chemistry An Asian Journal, 2016, 11, 310
DOI: 10.1002/asia.201501048

Ru(II) complexes bearing guanidinium ligands as potent anticancer agents

Wen-Xiu Chen, Xing-Dong Song, Shu-Fen He, Jing Sun, Jia-Xi Chen, Tie Wu and Zong-Wan Mao

Journal of Inorganic Biochemistry, 2016, 164, 91
DOI: 10.1016/j.jinorgbio.2016.09.004

Rational Design of Ruthenium Complexes Containing 2,6‐Bis(benzimidazolyl)pyridine Derivatives with Radiosensitization Activity by Enhancing p53 Activation

Zhiqin Deng, Lianling Yu, Wenqiang Cao, Wenjie Zheng and Tianfeng Chen

ChemMedChem, 2015, 10, 991
DOI: 10.1002/cmdc.201500127

In vitro evaluation of cytotoxicity and antimetastatic properties of novel arene ruthenium(II)‐tetrazolato compounds on human cancer cell lines

Komal M. Vyas, Deepu Sharma, Sri Krishna Jayadev Magani, Shaikh M. Mobin and Suman Mukhopadhyay

Applied Organom Chemis, 2021, 35
DOI: 10.1002/aoc.6187

Design and Synthesis of 2‐(5‐Phenylindol‐3‐yl)benzimidazole Derivatives with Antiproliferative Effects towards Triple‐Negative Breast Cancer Cells by Activation of ROS‐Mediated Mitochondria Dysfunction

Mengying Wang, Yusheng Wu, Cuifang Xu, Rucheng Zhao, Yanyu Huang, Xiangchao Zeng and Tianfeng Chen

Chemistry An Asian Journal, 2019, 14, 2648
DOI: 10.1002/asia.201900468

Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η6-p-cymene) complex in human non-small cell lung cancer via p53-dependent pathway

Muhammad Zeeshan Bhatti, Amjad Ali, Hong-Quan Duong, Jiwu Chen and Faiz-Ur Rahman

Journal of Inorganic Biochemistry, 2019, 194, 52
DOI: 10.1016/j.jinorgbio.2019.01.019

Synthesis, characterization and anticancer activity of two Ru(II) polypyridyl complexes [Ru(dpq)2L](PF6)2 (L = maip, paip)

Shu-Fen He, Bing-Bing Chen, Ye-Hua Hao, Jia-Xi Chen, Xing-Dong Song, Jun Mei, Wen-Xiu Chen and Jing Sun

Inorganica Chimica Acta, 2018, 480, 62
DOI: 10.1016/j.ica.2018.05.006

Metal-based anticancer chemotherapeutic agents

Nafees Muhammad and Zijian Guo

Current Opinion in Chemical Biology, 2014, 19, 144
DOI: 10.1016/j.cbpa.2014.02.003

Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes

Adriana Grozav, Ovidiu Balacescu, Loredana Balacescu, Thomas Cheminel, Ioana Berindan-Neagoe and Bruno Therrien

J. Med. Chem., 2015, 58, 8475
DOI: 10.1021/acs.jmedchem.5b00855

Mitochondrial Fragmentation Is an Important Cellular Event Induced by Ruthenium(II) Polypyridyl Complexes in Osteosarcoma Cells

Yanxin Du, Xiaoyan Fu, Hong Li, Bolai Chen, Yuhai Guo, Guoyi Su, Hu Zhang, Feipeng Ning, Yongpeng Lin, Wenjie Mei and Tianfeng Chen

ChemMedChem, 2014, 9, 714
DOI: 10.1002/cmdc.201300379

Ru(II)(ƞ6-p-cymene) Conjugates Loaded onto Graphene Oxide: An Effective pH-Responsive Anticancer Drug Delivery System

Suffora Akhter, Farukh Arjmand, Claudio Pettinari and Sartaj Tabassum

Molecules, 2022, 27, 7592
DOI: 10.3390/molecules27217592

A ruthenium(II) complex containing a p-cresol group induces apoptosis in human cervical carcinoma cells through endoplasmic reticulum stress and reactive oxygen species production

Li Xu, Pei-Pei Zhang, Xiao-Qiang Fang, Yan Liu, Jin-Quan Wang, Hui-Zhuo Zhou, Shu-Ting Chen and Hui Chao

Journal of Inorganic Biochemistry, 2019, 191, 126
DOI: 10.1016/j.jinorgbio.2018.11.015

Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro

Guang-Bin Jiang, Wen-Yao Zhang, Miao He, Yi-Ying Gu, Lan Bai, Yang-Jie Wang, Qiao-Yan Yi and Fan Du

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2019, 220, 117132
DOI: 10.1016/j.saa.2019.05.037

Comprehensive Insights into Medicinal Research on Imidazole-Based Supramolecular Complexes

Shu-Rui Li, Yi-Min Tan, Ling Zhang and Cheng-He Zhou

Pharmaceutics, 2023, 15, 1348
DOI: 10.3390/pharmaceutics15051348

A NEW La(III) COMPLEX CONSTRUCTED BY A LONG FLEXIBLE LIGAND: CRYSTAL STRUCTURE, DNA BINDING, AND MOLECULAR DOCKING STUDIES

M. Zhu, X. Ji, Y. Zhou, S. Li, H. Bao, J. Xu, E. Gao and X. Zhu

J Struct Chem, 2021, 62, 1139
DOI: 10.1134/S0022476621070192

A NEW MONOMER Ce(III) COMPLEX BASED ON BIS[(2-PYRIDYL)METHYLENE]PYRIDINE- 2,6-DICARBOHYDRAZONE: SYNTHESIS, DNA BINDING, APOPTOSIS, AND MOLECULAR DOCKING

S. Y. Chen, X. X. Ji, D. X. Song, Q. Chen, Y. Li, N. Sun, L. Wang, S. Y. Wu, Y. Zhang and M. C. Zhu

J Struct Chem, 2022, 63, 1568
DOI: 10.1134/S0022476622100031

p53 dependent apoptosis and cell cycle delay induced by heteroleptic complexes in human cervical cancer cells

Gunjan Sharma, Nishant Kumar Rana, Priya Singh, Pradeep Dubey, Daya Shankar Pandey and Biplob Koch

Biomedicine & Pharmacotherapy, 2017, 88, 218
DOI: 10.1016/j.biopha.2017.01.044